✦ LIBER ✦

84 Phase II study of topotecan in refractory and sensitive small cell lung cancer (SCLC)

✍ Scribed by A. Ardizzoni; H.H. Hansen; P. Dombernowsky; S. Kaplan; P.E. Postmus; T. Gamucci; B. Schaefer; J. Wanders; J. Rweij

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of topotecan (TOP) for re

✍ Ogawara, M; Negoro, S; Nishiwaki, Y; Fukuoka, M; Watanabe, K; Niitani, H 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 142 KB

EORTC LCCG Phase II study of topotecan i

✍ Ardizzoni, A; Manegold, C; Debruyne, C; Gaafar, R; Buchholz, E; Dussenne, S; Leg 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Late phase II trials of topotecan (T) fo

✍ Y. Nishiwaki; S. Negoro; K. Watanabe; M. Fukuoka; H. Niitani 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Randomised Phase II study of topotecan/c

✍ Gervais, R; Quoix, E; Mattson, K; Schramel, F.M; Rivière, A; Fields, S; Wheatley 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Phase II study of sequential dose-dense

✍ L. Santome; E. Felip; R. Rosell; M. Domine; A. Font; P. Garrido; A. Carrato; J. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Paclitaxel and gemcitabine for refractor

✍ M. Domine; J. Gonzalez Larriba; R. Garcia Gomez; S. Morales; D. Isla; C. Garcia 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 339 KB